BioSpace News Archive

Drug Development

Kezar Stock Soars on Positive Lupus Nephritis Data

Kezar Life Sciences stock rose 92% after it announced positive topline results from its Phase II clinical trial investigating the use of zetomipzomib for the treatment of Lupus Nephritis (LN).

June 28, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

Roivant Reduces Pipeline by Several Programs Across Vants

Roivant Sciences announced it has discontinued development of several assets following a pipeline reprioritization.

June 28, 2022
·
3 min read
·
Alex Keown
Business

Boehringer Expands BiomX IBD Biomarker Collab, Shutters Crohn’s Trial

Boehringer and BiomX intend to use the discovery platform to identify biomarkers for a pathogenic bacterium thought to be associated with IBD.

June 28, 2022
·
3 min read
·
Alex Keown
Business

Pfizer, Roivant Unveil Priovant with High Potential TYK2/JAK1 Inhibitor

Pfizer and Roivant unveiled Priovant Therapeutics to develop and market new therapies for a wide range of autoimmune diseases with high mortality and morbidity rates.

June 28, 2022
·
2 min read
·
Vanessa Doctor, RN
Harvard Researchers Uncover Insight into T Cells and Autoimmune Disease

Researchers from Harvard Medical School have published data in Science Daily involving the role of T cells in autoimmune diseases.

June 28, 2022
·
2 min read
·
Hayley Shasteen
Biotech Beach

GOODLIFE SURGERY CENTER NOW OFFERING INNOVATIVE TECHNOLOGY IN TOTAL KNEE REPLACEMENT WITH STRYKER’S MAKO SMARTROBOTICS™

Goodlife Surgery Center is the first and only Ambulatory Surgery Center in the South Bay to offer Mako SmartRobotics™.

June 28, 2022
·
2 min read
Micro-pumps Market Size to Hit Around USD 6.9 Billion by 2030

According to Latest Study, the global micro-pumps market was surpassed at USD 1.7 billion in 2021 and is expected to hit around USD 6.9 billion by 2030, growing at a CAGR of 16.84% from 2022 to 2030.

June 28, 2022
·
9 min read
Foot and Mouth Disease (FMD) Vaccines Market Size, Growth, Report 2022-2030

The global Foot and Mouth Disease (FMD) Vaccines market size is estimated to be worth US$ 1046 million in 2021 and is forecast to a readjusted size of US$ 2001.8 million by 2028 with a CAGR of 9.6% during the forecast period 2022-2030.

June 28, 2022
·
4 min read
Acetyl-L Carnitine (ALC) Market a CAGR of 4.5% during the forecast period 2022-2030

The global Acetyl-L Carnitine (ALC) market size is estimated to be worth US$ 51 million in 2021 and is forecast to a readjusted size of US$ 70 million by 2028 with a CAGR of 4.5% during the forecast period 2022-2030.

June 28, 2022
·
4 min read
Subcutaneous Immunoglobulins Market Size to Reach US$ 9807.2 Million by 2028

The global Subcutaneous Immunoglobulins market size is estimated to be worth US$ 4371.4 million in 2021 and is forecast to a readjusted size of US$ 9807.2 million by 2028 with a CAGR of 12.1% during the forecast period 2022-2030.

June 28, 2022
·
4 min read